 |
 |
||||||||||||||
|
|
| OAPI Contact Us |
|
Thank you for your interest in OAPI. We're happy to answer questions about our company, and you can also find additional information on our website by clicking on these topics: Please note that we cannot provide answers to personal medical questions. To obtain such answers you should contact your healthcare provider. Also note that this system is not designed to respond to product complaints. For questions/comments regarding ABILIFY® (aripiprazole) Tablets1, call (800) 321-1335 For questions/comments regarding PLETAL® (cilostazol) Tablets2, call Otsuka's Medical Affairs Department at (800) 441-6763 toll free For questions/comments regarding BreathTekTM Urea Breath Test (UBT)3 call (888) 637-3835 For questions/comments regarding IV Busulfex® (busulfan)4 call Otsuka's Medical Affairs Department at (800) 441-6763 toll free For information regarding Otsuka's Adacolumn clinical trials for ulcerative colitis or Crohn's disease, call (866) 560-5828 or e-mail adacolumn@robarts.ca For information regarding Otsuka's Polycystic Kidney Disease clinical trials, call (866) 712-5837 We are not currently enrolling additional patients in Otsuka's Hyponatremia clinical trials, however, please continue to monitor www.clinicaltrials.gov for future informationWe are not currently enrolling additional patients in Otsuka's Dry Eye clinical trials, however, please continue to monitor www.clinicaltrials.gov for future information Corporate Headquarters/General Inquiries Career Information/Resumes Media Contact/Public Relations (U.S.) OAPI Medical Information Questions About Otsuka Pharmaceutical Products (U.S. Residents Only)
1 Please see FULL PRODUCT INFORMATION including Boxed WARNINGS for ABILIFY. 4 Please see FULL PRODUCT INFORMATION including Boxed WARNING for IV BUSULFEX. |
| * OAPI, OPDC and OMML are subsidiaries of Otsuka America, Inc. (OAI), a holding company established in the U.S. in 1989. OAI is wholly owned by Otsuka Pharmaceutical Co., Ltd.
|